首页> 美国卫生研究院文献>Clinical and Diagnostic Laboratory Immunology >Development of an Unbiased Antigen-Mining Approach To Identify Novel Vaccine Antigens and Diagnostic Reagents for Bovine Tuberculosis
【2h】

Development of an Unbiased Antigen-Mining Approach To Identify Novel Vaccine Antigens and Diagnostic Reagents for Bovine Tuberculosis

机译:开发一种用于鉴定新型疫苗抗原和牛结核病诊断试剂的无偏抗原挖掘方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Previous experiments for the identification of novel diagnostic or vaccine candidates for bovine tuberculosis have followed a targeted approach, wherein specific groups of proteins suspected to contain likely candidates are prioritized for immunological assessment (for example, with in silico approaches). However, a disadvantage of this approach is that the sets of proteins analyzed are restricted by the initial selection criteria. In this paper, we describe a series of experiments to evaluate a nonbiased approach to antigen mining by utilizing a Gateway clone set for Mycobacterium tuberculosis, which constitutes a library of clones expressing 3,294 M. tuberculosis proteins. Although whole-blood culture experiments using Mycobacterium bovis-infected animals and M. bovis BCG-vaccinated controls did not reveal proteins capable of differential diagnosis, several novel immunogenic proteins were identified and prioritized for efficacy studies in a murine vaccination/challenge model. These results demonstrate that Rv3329-immunized mice had lower bacterial cell counts in their spleens following challenge with M. bovis. In conclusion, we demonstrate that this nonbiased approach to antigen mining is a useful tool for identifying and prioritizing novel proteins for further assessment as vaccine antigens.
机译:用于鉴定牛结核的新型诊断或疫苗候选物的先前实验已经遵循了靶向方法,其中将疑似包含可能候选物的特定蛋白质组优先用于免疫学评估(例如,计算机方法)。但是,这种方法的缺点是所分析的蛋白质组受到初始选择标准的限制。在本文中,我们描述了一系列实验,通过利用针对结核分枝杆菌的Gateway克隆集来评估抗原开采的无偏方法,该网关克隆集构成了表达3294结核分枝杆菌蛋白的克隆的文库。尽管使用牛分枝杆菌感染的动物和牛分枝杆菌BCG接种的对照进行的全血培养实验未揭示能够进行鉴别诊断的蛋白质,但已鉴定出几种新型免疫原性蛋白质,并优先考虑在鼠疫苗接种/挑战模型中进行功效研究。这些结果表明,用牛分枝杆菌攻击后,经Rv3329免疫的小鼠脾脏细菌细胞数较低。总而言之,我们证明了这种用于抗原挖掘的无偏方法是一种有用的工具,可用于识别和区分新型蛋白并作为疫苗抗原进行进一步评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号